Headaches, Phase I
Repeat Dosing of Psilocybin in Migraine Headache
Volunteers
Health Professionals
What is the purpose of this trial?
In seeking to understand the capacity for psilocybin to reduce migraine headache burden, this study will investigate single and repeated dosing of psilocybin up to two doses. In seeking to identify an underlying mechanism in psilocybin's effects, neuroinflammatory markers for migraine headache will be measured.
- Trial withWallace Research Foundation
- Ages21 years - 65 years
- GenderBoth
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigator
- Last Updated12/22/2022
- Study HIC#2000026974